Mydriasis Treatment Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Mydriasis Treatment Market is segmented By Type (Anticholinergic Agents, Adrenergic Agonists), By Route of Administration (Topical, Systemic), By Application (Diagnostic, Surgical, Therapeutic), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD million) for the above-mentioned.
Mydriasis Treatment Market Size
Market Size in USD
CAGR4.8%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 4.8% |
| Market Concentration | High |
| Major Players | Alcon, Novartis AG, Bausch & Lomb, Allergan plc, Pfizer Inc., Santen Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries Ltd., Akorn, Inc. |
please let us know !
Mydriasis Treatment Market Analysis
The mydriasis treatment market is estimated to be valued at USD 633.3 Mn in 2024 and is expected to reach USD 878 Mn by 2031, growing at a compound annual growth rate (CAGR) of 4.8% from 2024 to 2031. The mydriasis treatment market has been witnessing significant growth over the past few years. The increasing prevalence of eye diseases such as glaucoma, cataract, diabetic retinopathy and others have been driving the need for effective mydriasis treatments.